Lotrisone
Temporary Tattoos May Put You at Risk »
"Spring break is on the way, or maybe summer vacation. Time to pack your swim suit, hit the beach, and perhaps indulge in a little harmless fun. What about getting a temporary tattoo to mark the occasion? Who could it hurt to get a temporary tatto"...
Lotrisone
INDICATIONS
LOTRISONE® (clotrimazole and betamethasone) Cream and Lotion are indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis due to Epidermophyton floccosum, Trichophyton mentagrophytes, and Trichophyton rubrum. Effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid, especially for noninflammatory tinea infections. The efficacy of LOTRISONE (clotrimazole and betamethasone) Cream or Lotion for the treatment of infections caused by zoophilic dermatophytes (eg, Microsporum canis) has not been established. Several cases of treatment failure of LOTRISONE (clotrimazole and betamethasone) Cream in the treatment of infections caused by Microsporum canis have been reported.
DOSAGE AND ADMINISTRATION
Gently massage sufficient LOTRISONE® (clotrimazole and betamethasone) Cream or Lotion into the affected skin areas twice a day, in the morning and evening.
LOTRISONE (clotrimazole and betamethasone) Cream or Lotion should not be used longer than 2 weeks in the treatment of tinea corporis or tinea cruris, and amounts greater than 45 g per week of LOTRISONE (clotrimazole and betamethasone) Cream or amounts greater than 45 mL per week of LOTRISONE (clotrimazole and betamethasone) Lotion should not be used. If a patient with tinea corporis or tinea cruris shows no clinical improvement after 1 week of treatment with LOTRISONE (clotrimazole and betamethasone) Cream or Lotion, the diagnosis should be reviewed.
LOTRISONE (clotrimazole and betamethasone) Cream or Lotion should not be used longer than 4 weeks in the treatment of tinea pedis and amounts greater than 45 g per week of LOTRISONE (clotrimazole and betamethasone) Cream or amounts greater than 45 mL per week of LOTRISONE (clotrimazole and betamethasone) Lotion should not be used. If a patient with tinea pedis shows no clinical improvement after 2 weeks of treatment with LOTRISONE (clotrimazole and betamethasone) Cream or Lotion, the diagnosis should be reviewed.
LOTRISONE (clotrimazole and betamethasone) Cream or Lotion should not be used with occlusive dressings.
HOW SUPPLIED
LOTRISONE® (clotrimazole and betamethasone) Cream is supplied in 15-g (NDC 0085-0924-01) and 45-g tubes (NDC 0085-0924-02); boxes of one. Store at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].
LOTRISONE® (clotrimazole and betamethasone) Lotion is supplied in 30-mL bottles (NDC 0085-0809-01), box of one. Store at 25°C (77°F) in the upright position only; excursions permitted between 15°C and 30°C (59°F and 86°F).
SHAKE LOTION WELL BEFORE EACH USE.
Schering Corporation. Kenilworth, NJ 07033 USA. Revised. May 2009.
Last reviewed on RxList: 6/10/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Lotrisone Information
Lotrisone - User Reviews
Lotrisone User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Lotrisone sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
